Small Cell Lung Cancer Clinical Trials in Peoria, Illinois

4 studies are recruiting for small cell lung cancer in Peoria, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

   Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, and brain. The purpose of this study is to assess safety, tolerability, and change in disease activi…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   OSF St. Francis Medical Center /ID# 279930, Peoria, Illinois

   Locations

   63 in total

   Run by

   AbbVie

   See if you can join NCT07365241 on ClinicalTrials.gov

2. A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

   The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Illinois Cancer Care, Peoria, Illinois

   Locations

   155 in total

   Run by

   Zai Lab (Shanghai) Co., Ltd.

   See if you can join NCT07218146 on ClinicalTrials.gov

3. Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

   This is an open-label study of NMS-03305293 with Temozolomide (TMZ) in patients with Small Cell Lung Cancer (SCLC). The aim of this study is to determine the safety and tolerability, as well as to evaluate the anti-tumor efficacy and pharmacokinetics of NMS-03305293 in combination with TMZ.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   OSF Saint Francis Medical Center, Peoria, Illinois

   Locations

   3 in total

   Run by

   Nerviano Medical Sciences

   See if you can join NCT06931626 on ClinicalTrials.gov

4. Tempus Small Cell Lung Cancer Observational Study (Sculptor)

   The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line trea…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Illinois Cancer Care, Peoria, Illinois

   Locations

   11 in total

   Run by

   Tempus AI

   See if you can join NCT05257551 on ClinicalTrials.gov